15 results
·
25ms
·
Sources: EU EUDAMED, US FDA
DILUENT, CELLENT BLOOD
FDA 510(k)
FDA Class 1
·Hematology
ReLine
FDA UDI
Nuvasive, Inc.·00887517010643·RELINE-C Caliper, Cross Connector
TRUMPF MEDICAL
FDA UDI
Baxter Medical Systems GmbH + Co. KG·00887761990357·Table top segment Carbon 600 V
Trimline
FDA UDI
ORMCO CORPORATION·00889989051001·UPPER RIGHT FIRST MOLAR TRIMLINE BAND SIZE 28
APEX Knee System
FDA UDI
Omni Life Science, Inc.·00841690196464·AK3 Patella Resection Guide w/ Offset
Controller, Closed-Loop Blood Glucose
FDA Pre-Market Approval
FDA Class 3
·BIOSTATOR GCIIS
CPK - ISOENZYMES
FDA 510(k)
FDA Class 2
·Clinical Chemistry
UNO 30
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Controller, Closed-Loop Blood Glucose
FDA Pre-Market Approval
FDA Class 3
·BIOSTATOR GCIIS
Controller, Closed-Loop Blood Glucose
FDA Pre-Market Approval
FDA Class 3
·BIOSTATOR GCIIS
FEM PRC LT M/RT L SML FEM PRC RT M/LT L SML FEM PRC LT M/RT L SML+ FEM PRC RT M/LT L SML+ FEM PRC LT M/RT L REG FEM PRC RT M/LT L REG FEM PRC LT M/RT L REG+ FEM PRC RT M/LT L REG+ FEM PRC LT M/RT L LGE FEM PRC RT M/LT L LGE FEM PRC LT M/RT L LGE+ FEM PRC RT M/LT L LGE+ " These devices are indicated for patients with: - Painful and/or disabling knee joints due to osteoarthritis or traumatic arthritis. - Previous tibial condyle or plateau fractures with loss of anatomy or function. - Varus or valgus deformities. - Revision of previous arthroplasty procedures. " These devices are indicated for cemented use only. " The Zimmer Unicompartmental Knee System is designed for use when load bearing ROM is expected to be less than or equal to 155 degrees.
FDA Enforcement
Class II
·Terminated·Zimmer Biomet, Inc.·March 21, 2018
STERNAL ZIPFIX WITH NEEDLE STERILE / 5 PACK
FDA Adverse Event
Injury
·SYNTHES BETTLACH·Product code JDQ·May 5, 2014
SPECTRAFLEX
FDA Adverse Event
Injury
·MEDTRONIC PUERTO RICO, INC.·Product code DTB·October 15, 2012
FREESTYLE FLASH
FDA Adverse Event
Malfunction
·ABBOTT DIABETES CARE INC, USA·Product code LFR·July 26, 2007
ACCOLADE SR SL MRI (Model L310)
FDA Enforcement
Class I
·Ongoing·Boston Scientific Corporation·October 22, 2025